This project will examine new methodology for important issues in the analysis of censored failure time data. The methodology addresses problems occurring frequently in clinical investigations for chronic diseases, including cancer and AIDS. The specific objectives of the project are to: 1. Develop and study nonparametric methods for incorporating information on disease progression in the analysis of survival, to improve the efficiency of estimates and tests. An example where this would be useful is in clinical trials for adjuvant breast cancer therapy. At times of analysis there will usually be a substantial number of patients who have relapsed but are still alive, so incorporating information on recurrence should improve the analysis of survival. 2. Explore methods for modeling the distribution of times between repeated events. There are many models of varying complexity that can be used for multiple event data. This project will explore the effect on bias and efficiency from using incorrect models, and investigate tests for discriminating among models. 3. Develop methods for regression analysis of censored failure time data with partially missing information on covariates. Partially missing covariate data is a frequent problem in biomedical research. Both semi-parametric methods which involve finding unbiased estimating equations, and Bayesian methods which require full specification of the joint distributions, will be investigated. 4. Investigate methodology for detecting and estimating treatment by institution interactions in multi-center clinical trials. Large phase III trials of cancer therapy usually include patients from many hospitals and clinics. In this project treatment differences for individual institutions will be modeled as random effects. Overall tests for treatment by institution interactions, and Bayesian methods for estimating the treatment effects, will both be investigated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA057253-01
Application #
3201557
Study Section
Special Emphasis Panel (SSS (R7))
Project Start
1992-07-01
Project End
1995-06-30
Budget Start
1992-07-01
Budget End
1993-06-30
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Gray, Robert J (2003) Weighted estimating equations for linear regression analysis of clustered failure time data. Lifetime Data Anal 9:123-38
Li, Yi; Betensky, Rebecca A; Louis, David N et al. (2002) The use of frailty hazard models for unrecognized heterogeneity that interacts with treatment: considerations of efficiency and power. Biometrics 58:232-6
Gray, Robert J; Li, Yi (2002) Optimal weight functions for marginal proportional hazards analysis of clustered failure time data. Lifetime Data Anal 8:5-19
Li, Yi; Ryan, Louise (2002) Modeling spatial survival data using semiparametric frailty models. Biometrics 58:287-97
Gray, R J (2000) Estimation of regression parameters and the hazard function in transformed linear survival models. Biometrics 56:571-6
Lipsitz, S R; Molenberghs, G; Fitzmaurice, G M et al. (2000) GEE with Gaussian estimation of the correlations when data are incomplete. Biometrics 56:528-36
Parzen, M; Lipsitz, S R (1999) A global goodness-of-fit statistic for Cox regression models. Biometrics 55:580-4
Lipsitz, S R; Ibrahim, J G; Fitzmaurice, G M (1999) Likelihood methods for incomplete longitudinal binary responses with incomplete categorical covariates. Biometrics 55:214-23
Lipsitz, S R; Dear, K B; Laird, N M et al. (1998) Tests for homogeneity of the risk difference when data are sparse. Biometrics 54:148-60
Gray, R J (1998) On tests for group variation with a small to moderate number of groups. Lifetime Data Anal 4:139-48

Showing the most recent 10 out of 15 publications